Results 91 to 100 of about 10,998 (173)

SF3B1 mutations in patients with myelodysplastic syndromes: The mutation is stable during disease evolution

, 2018
[[abstract]]The SF3B1 mutation can be detected in patients with myelodysplastic syndrome (MDS), but the report regarding the association of this mutation with other genetic alterations and its stability during disease progression is limited.
Lin, Chien Chin;Hou, Hsin An;Chou, Wen Chien;Kuo, Yuan Yeh;Wu, Shang Ju;Liu, Chieh Yu;Chen, Chien Yuan;Tseng, Mei Hsuan;Huang, Chi Fei;Lee, Fen Yu;Liu, Ming Chih;Liu, Chia Wen;Tang, Jih Luh;Yao, Ming;Huang, Shang Yi;Hsu, Szu Chun;Ko, Bor Sheng;Tsay, Woei;Chen, Yao Chang;Tien, Hwei Fang
core  

Clinical implications of variant allele frequencies of genes in patients with acute myeloid leukemia. [PDF]

Oncologist
Zhao L, Cheng F, Wei J, Liu R, Zhao Q, Zhang Y, Li Y.   +6 more
europepmc   +1 more source

Essential HDRescue: A Co-Targeting Strategy to Enhance Precision Genome Editing by Co-Editing Essential Genes. [PDF]

Cells
Siwak JF, Connelly JP, Pruett-Miller SM.
europepmc   +1 more source

SF3B1 mutations in patients with myelodysplastic syndromes: the mutation is stable during disease evolution

[[abstract]]The SF3B1 mutation can be detected in patients with myelodysplastic syndrome (MDS), but the report regarding the association of this mutation with other genetic alterations and its stability during disease progression is limited.
Wu, Shang-Ju, Tang, Jih-Luh, Ko, Bor-Sheng, Lin, Chien-Chin, Hou, Hsin-An, Chou, Wen-Chien, Huang, Chi-Fei, Yao, Ming, Liu, Chieh-Yu, Tsay, Woei, Tseng, Mei-Hsuan, Liu, Ming-Chih, Hsu, Szu-Chun, Chen, Yao-Chang, Chen, Chien-Yuan, Lee, Fen-Yu, Kuo, Yuan-Yeh, Huang, Shang-Yi, Liu, Chia-Wen, Tien, Hwei-Fang   +19 more
core  

CMML is in the eye of the be-WHO-lder: interrogating the newly proposed entity of oligomonocytic CMML: MDS or CMML? [PDF]

Blood Neoplasia
Komrokji RS, Komrokji Z, Al Ali NH, Xie Z, Chan O, Kuykendall AT, Walker AR, Yun S, Reynolds SB, Shallis R, Lancet JE, Sallman DA, Padron E.   +12 more
europepmc   +1 more source

Clinical Characteristics and Molecular Profiling of <i>SF3B1</i>-Mutated Myelodysplastic Syndrome (MDS) in a Real-World Practice. [PDF]

Int J Mol Sci
Wang RR, Than H, Tham C, How GF, Khoo SJ, Tuy TT.   +5 more
europepmc   +1 more source

SF3B1 mutation arises at the multipotent HSC level [PDF]

Blood, 2017
openaire   +2 more sources

SF3B1 mutation as a predictive biomarker for luspatercept efficacy in myeloproliferative neoplasms and MDS/MPN: a clinical study. [PDF]

Ann Hematol
Cui T, Gong J, Zhang X, Zhang J, Wei N, Zheng W, Duan M.   +6 more
europepmc   +1 more source

De novo variants in the splicing factor gene SF3B1 are associated with neurodevelopmental disorders. [PDF]

Nat Commun
Uguen K, Bergot T, Scott-Boyer MP, Chapalain S, Desdouets C, Commet S, Zhu C, Xu Y, Wang Y, Roscioli T, Tran-Mau-Them F, Faivre L, Maraval J, Delanne J, Denommé-Pichon AS, Vitobello A, Jost C, Planes M, Hiatt S, Wheeler P, Gonzaga-Jauregui C, Wang H, Xin B, Sency V, Kruer MC, Bakhtiari S, Sulem P, Curry C, Prescott T, Strobl-Wildemann G, Brunet T, Doco Fenzy M, Courtin T, Poirsier C, Bjørg Hammer T, Fenger CD, MacPherson M, Izumi K, Leonard J, Li D, Zackai EH, Glass IA, Ward S, Campeau PM, Borroto MCH, Le Moigno L, Van Esch H, De Waele L, Calame DG, Lupski JR, Barcia G, Peduto C, Planté-Bordeneuve P, Dupuis L, Mendoza-Londono R, Stavropoulos DJ, Gillibert-Duplantier J, Besnard T, Do Souto Ferreira L, Cogné B, Bézieau S, Droit A, Corcos L, Lippert E, Férec C, Küry S, Bernard DG.   +66 more
europepmc   +1 more source

Application of next-generation sequencing in the treatment of myelodysplastic syndrome: from mechanisms to clinical practice. [PDF]

Blood Sci
Ma YY, Zhang C, Chen Y, Zeng L, Zhang X.
europepmc   +1 more source